Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Epizyme synthesizes novel DOT1-like protein inhibitors

July 6, 2012

Roche divulges novel Mdm2/p53 interaction inhibitors

July 6, 2012

Phase I/Ib trial evaluates AUY-922 alone and with bortezomib

July 6, 2012

Encouraging phase II results presented on PD-0332991

July 6, 2012

EXPAND trial in advanced gastric cancer does not meet primary endpoint

July 5, 2012

SB-485232/PLD combination shows acceptable safety in ovarian cancer

July 5, 2012

Maximum tolerated dose of NKP-1339 determined in first-in-human trial

July 5, 2012

Novel bromodomain-containing protein inhibitors synthesized

July 5, 2012

New KIF11 inhibitors discovered in Japan

July 5, 2012

Phase I results available for OPB-51602

July 5, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.